Virbac S.A.

Virbac S.A.

VRBCF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.21B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Virbac S.A.Virbac S.A.19.10.41%24%1.10.3
$384.84

Current Fair Value

0.4% upside

Undervalued by 0.4% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.21 Billion
Enterprise Value$3.40 Billion
Annual dividend$1.66
Dividend yield0.41%
Earnings per Share$17.98
Beta0.78
Outstanding Shares8,378,475

Return

Return on Equity23.68%ROE
Return on Assets13.85%
Return on Invested Capital29.71%

Valuation & Multiples

P/E Ratio19.09P/E Ratio
PEG367.01PEG
Price to Sales1.1Price to Sales
Price to Book Ratio2.64Price to Book Ratio
Enterprise Value to Revenue1.16
Enterprise Value to EBIT7.27
Enterprise Value to Net Income11
Total Debt to Enterprise0.11
Debt to Equity0.3Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 17, 2026
EPS
$11.83
Reported
Revenue
$877.10 M
Est. $877.10 M

Next Earnings Call

Expected Date
March 23, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Virbac S.A.

6,442 employees
CEO: Paul Martingell

Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North ...